Frontlight ResearchEarly access
CompletedNo phase
Noninvasive Brain Stimulation to Enhance Cognition at Home Following a TBI.
Key facts
- Who runs it
- Shirley Ryan AbilityLab
- Where
- Chicago, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 7 people enrolled
- Started
- 9 Jan 2026
- Ended
- 27 Apr 2026
- Type of study
- Interventional
- Treatments tested
- Transcutaneous Vagus Nerve Stimulation (tVNS)
- Record updated
- 18 June 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- Age 18-75 years; Formally diagnosed with traumatic brain injury; Ability to independently use a keyboard; Able to understand and communicate in English (according to clinical judgment); Able to independently provide consent to participate
Who cannot take part
- Acute medical issues requiring close physician or nursing monitoring; Bioelectrical implants, cerebral shunts, including pacemakers; Anyone with sore or diseased skin area in the ear; Pregnancy or persons who are lactating; Cardiac arrhythmia; Epilepsy or seizure disorders; Significant gross or fine motor weakness; Significant, ongoing communication or comprehension impairments (such as aphasia) that would affect an individual's ability to complete the required assessments; Severely impaired memory retention (Score lower than 3 in the 3 Word Delayed Recall test attached to this submission); Current major depression diagnosis
Where in United States
- Shirley Ryan AbilityLabChicago, United States
About the trial
What the trial wants to find out
The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous vagus nerve stimulation (tVNS) at home, to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).
The group in the trial
- Active StimulationTreatment being tested
Active stimulation using trans auricular nerve stimulation device (tVNS), one hour a day for 14 days at home. Pre and post assessment occurring at day 0 and day 15.
Treatment: Transcutaneous Vagus Nerve Stimulation (tVNS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Enhancing Cognition After TBI Using Noninvasive Vagus Nerve Stimulation at Home
- Record updated
- 18 June 2026